RNAi Roundup: Qiagen Offers RNAi Expertise to SARS Scientists; Antisense Beats RNAi to SARS Drug Starting Line; RNAi Research Reveals Secrets of Algal Sex Cycle | GenomeWeb

NEW YORK, April 25 -Qiagen has lent its RNAi expertise to scientists on the front lines of SARS research, stepping in to contribute its RNA interference design resource, along with its custom siRNA and other sample preparation and nucleic acid chemistry products to laboratories in Hong Kong, China, Singapore, and Canada, the company said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.